KALEIDO BIOSCIENCES INC's ticker is KLDO and the CUSIP is 483347100. A total of 71 filers reported holding KALEIDO BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 3.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $718,000 | -30.2% | 435,024 | +1.2% | 0.00% | – |
| Q4 2021 | $1,028,000 | -57.6% | 429,987 | -3.1% | 0.00% | – |
| Q3 2021 | $2,423,000 | -13.4% | 443,804 | +18.1% | 0.00% | – |
| Q2 2021 | $2,797,000 | +72.1% | 375,907 | +87.3% | 0.00% | – |
| Q1 2021 | $1,625,000 | -5.5% | 200,664 | +6.2% | 0.00% | – |
| Q4 2020 | $1,719,000 | -7.3% | 188,943 | +12.8% | 0.00% | – |
| Q3 2020 | $1,854,000 | +43.8% | 167,443 | -3.5% | 0.00% | – |
| Q2 2020 | $1,289,000 | +42.3% | 173,445 | +17.8% | 0.00% | – |
| Q1 2020 | $906,000 | +52.0% | 147,286 | +24.0% | 0.00% | – |
| Q4 2019 | $596,000 | -0.3% | 118,823 | +49.5% | 0.00% | – |
| Q3 2019 | $598,000 | -3.7% | 79,475 | +14.9% | 0.00% | – |
| Q2 2019 | $621,000 | – | 69,175 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 19,575,710 | $158,562,000 | 2.54% |
| HARBOURVEST PARTNERS LLC | 1,833,832 | $14,854,000 | 1.99% |
| Trustees of Columbia University in the City of New York | 150,150 | $1,216,000 | 1.47% |
| Palo Alto Investors LP | 786,400 | $6,370,000 | 0.36% |
| Artal Group S.A. | 500,500 | $4,054,000 | 0.07% |
| EXANE DERIVATIVES | 21,333 | $172,790,000 | 0.05% |
| FEDERATED HERMES, INC. | 825,000 | $6,683,000 | 0.01% |
| Johnson Midwest Financial, LLC | 745 | $6,000 | 0.01% |
| Cerity Partners LLC | 18,500 | $150,000 | 0.00% |
| FMR LLC | 6,370,018 | $51,597,000 | 0.00% |